01840nas a2200277   4500000000100000008004100001260003400042653005700076653001700133653002400150653002100174100002200195700001100217700001300228700001300241700001300254700001300267700001300280700001300293700001700306700001500323245010200338856010400440520099300544022002501537       2021                            d  bOxford University Press (OUP)10aPublic Health, Environmental and Occupational Health10aParasitology10aInfectious Diseases10aGeneral Medicine1 aAmanyi-Enegela JA1 aBurn N1 aDirisu O1 aEbenso B1 aSankar G1 aIshaya R1 aOgoshi C1 aKumbur J1 aEkweremadu B1 aQureshi BM00aLessons from the field: delivering trachoma mass drug administration safely in a COVID-19 context  uhttps://academic.oup.com/trstmh/advance-article-pdf/doi/10.1093/trstmh/trab102/39270718/trab102.pdf3 a<jats:title>Abstract</jats:title>
               <jats:p>The first coronavirus disease 2019 (COVID-19) interim guidance released by the World Health Organization recommended suspension of non-urgent community health interventions, including mass drug administration (MDA) for neglected tropical diseases. However, with no end in sight for the COVID-19 pandemic, it was crucial to find ways to restart MDA while testing measures to reduce the risk of COVID-19 transmission between health workers, volunteers and communities. Consequently, guidelines were developed for delivering MDA safely in a COVID-19 context and the training and implementation were assessed through an observation checklist. The study also gathered data on the feasibility of using the MDA platform to disseminate COVID-19 health education. The results suggest that delivering MDA safely in a COVID-19 context is possible but revealed significant challenges in using the MDA platform for COVID-19 education.</jats:p>  a0035-9203, 1878-3503